Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC-6499 in Constipation Predominant IBS
NCT01149200Phase 2Completed
- Sponsor
- Targacept
- Start
- May 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simpinicline in irritable bowel syndrome with constipation (IBS-C), sponsored by Targacept. Started May 2010; status: completed.
02
Drugs
simpinicline
03
Conditions
irritable bowel syndrome with constipation (IBS-C)
Beyond the preview
Go deeper on NCT01149200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149200.